Latest news

Insights

The Science Behind Bispecific Antibodies and Their Therapeutic Potential

Executive Summary Bispecific antibodies are an increasingly important class of engineered biologic medicines designed to recognize two distinct molecular targets...
Insights

Top 10 Emerging Technologies in Microbial Biotechnology

Executive Summary Microbial biotechnology is advancing as new technologies expand the ability to engineer, understand, and utilize microorganisms for industrial,...
Commercial

Delix Therapeutics Raises $100 Million to Advance Zalsupindole for Depression

Delix Therapeutics has raised $100 million through an oversubscribed Series C financing round to advance its investigational psychedelic-derived medicine,...
Regulatory

Altimmune to Discuss Phase 3 Pemvidutide Program for Alcohol Use Disorder With FDA

Altimmune is scheduled to meet with the U.S. Food and Drug Administration (FDA) in December to discuss the design...
Insights

Top 10 Factors That Influence Clinical Trial Protocol Complexity

Executive Summary Clinical trial protocol complexity has become an important...
Insights

Risk-Based Monitoring Reimagined: The Next Evolution of Clinical Trial Oversight

   Executive Summary Clinical trial monitoring is shifting from traditional, site-intensive...
Manufacturing

99% of trial participants receive customised mRNA vaccinations from Merck and Moderna close to the market

Personalizing cancer vaccines is a step closer to market, as Merck and Moderna demonstrated that their mRNA vaccine, combined...
Commercial

AstraZeneca reportedly made a $10 billion deal for the sought-after metabolic jewel Rhythm

Shares of Rhythm Pharmaceuticals jumped 24% after rumors surfaced that AstraZeneca had put in a $10 billion proposal to...
Clinical

Cloudbreak Pharma’s CBT-001 Meets Phase 3 Endpoints in Pterygium Trial

Cloudbreak Pharma has reported statistically significant improvements in both primary endpoints of its Phase 3 trial evaluating CBT-001, an...
Commercial

Evommune Secures Huge Hinova Deal for Oral Autoimmune Drug

Evommune has struck a licensing agreement with China-based Hinova...
Insights

Top 10 Drug Discovery Platforms to Watch

Executive Summary Artificial intelligence is changing how pharmaceutical companies identify...
Insights

Launch Excellence in the Digital Era

Executive Summary Launching a pharmaceutical product has become increasingly complex. Scientific innovation alone does not guarantee commercial success. Market access...
Insights

Top 10 Factors That Determine the Success of a Drug Candidate

Executive Summary A promising drug candidate must overcome multiple scientific, clinical, regulatory, manufacturing, and commercial challenges before becoming an approved...
Insights

Spatial Biology and Its Commercial Potential

Executive Summary Spatial biology is emerging as an important capability in pharmaceutical research and precision medicine. By examining the location...
Top Industry Leaders 2026 award logo Awards · Nominations open Nominate for the Top Industry Leaders Award 2026 Recognize the senior executives moving pharma, biotech and medtech forward. Self-nominations welcome. Nominate now → Nominations close 15 January 2027
Commercial

Delix Therapeutics Raises $100 Million to Advance Zalsupindole for Depression

Delix Therapeutics has raised $100 million through an oversubscribed...
Editorial Team -
Commercial

Roche’s $3.5 billion acquisition of 89bio and its phase 3 mdication makes it a MASH player

Roche Enters MASH Market with Strategic Acquisition Roche has officially...
Commercial

Chiesi and Arbor Biotechnologies Enter $2 Billion Gene Therapy Partnership for Rare Liver Disease

A Landmark Collaboration in Gene Therapy Italy’s Chiesi Group and...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Vera Health, a clinical artificial intelligence search engine, has secured $28.5 million in Series...
Editorial Team -

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Regulatory

Insights

Top 10 Emerging Technologies in Microbial Biotechnology

Executive Summary Microbial biotechnology is advancing as new technologies expand...
Commercial

Delix Therapeutics Raises $100 Million to Advance Zalsupindole for Depression

Delix Therapeutics has raised $100 million through an oversubscribed...
Regulatory

Altimmune to Discuss Phase 3 Pemvidutide Program for Alcohol Use Disorder With FDA

Altimmune is scheduled to meet with the U.S. Food...
Manufacturing

Coherus Cuts Workforce By 30% to Prioritize Esophageal Cancer Treatment

Coherus Oncology is reducing its workforce by approximately 30%...

Research & Development

Market Access

Manufacturing

Ensoma Restructures Operations to Focus on EN-374 for X-Linked Chronic Granulomatous Disease

Boston-based biotechnology company Ensoma has carried out another organizational...
Manufacturing

Novo Nordisk Sues Eli Lilly Over GLP-1 Drug Advertising Claims

Novo Nordisk has filed a lawsuit against Eli Lilly...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

The Science Behind Bispecific Antibodies and Their Therapeutic Potential

Executive Summary Bispecific antibodies are an increasingly important class of...
Editorial Team -
Commercial

Delix Therapeutics Raises $100 Million to Advance Zalsupindole for Depression

Delix Therapeutics has raised $100 million through an oversubscribed...
Editorial Team -